Haemonetics | HAE - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Avanos Medical USD 94.2M 8.2M 2026-03
Baxter International USD 891M 314M 2026-03
Becton, Dickinson and Co. USD 2.15B 257M 2026-03
Boston Scientific USD 3.61B 64M 2026-03
Cerus USD 33.33M 8.66M 2024-12
Cooper Companies USD 695.2M 44.4M 2025-12
Fresenius EUR 1.51B 214M 2025-12
Fresenius Medical Care EUR 1.18B 210M 2026-03
Globus Medical USD 496.26M 39.69M 2026-03
Haemonetics USD 202.39M 7.64M 2025-12
ICU Medical USD 202.98M 2.1M 2025-12
Intuitive Surgical USD 1.83B 73.8M 2026-03
Masimo USD 250.8M 3.5M 2026-03
Medtronic USD 5.41B 27M 2025-12
Merit Medical Systems USD 184.8M 10.56M 2026-03
Neogen USD 99M 7.7M 2025-12
OraSure Technologies USD 11.34M 435K 2025-12
Plus Therapeutics 1.37M 30K 2025-12
Quidel USD -91.8M 366.6M 2026-03
ResMed USD 890.98M 12.26M 2026-03
STAAR Surgical USD 43.74M 34.13M 2025-12
Steris USD 655.5M 9.6M 2025-12
Stryker USD 3.81B 675M 2026-03
Surmodics USD 20.08M 31.62M 2025-06
Teleflex USD 307.43M 21K 2026-03
Terumo JPY 149.02B 4.17B 2026-03
Thermo Fisher Scientific USD 4.49B 146M 2026-03
US Physical Therapy USD 32.75M 7.38M 2026-03
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12